Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inositol polyphosphate-5-phosphatase F (INPP5F) is a large membrane-associated enzyme (128 kDa, 1132 amino acids) containing a Sac domain and is primarily responsible for dephosphorylating specific phosphoinositides, particularly phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. These actions position it as a modulator of key cellular processes such as endocytic recycling, cell migration, signal transduction, and STAT3/AKT pathway regulation. INPP5F plays roles in cardiac physiology, neural regeneration, and has implications for cancer biology and other diseases. No directly interacting drugs are listed in pharmacogenomic resources. As an enzyme modifying phosphoinositide signaling, it shares molecular relationships with OCRL and other Sac domain phosphatases, distinguishing its function from related phosphatases in cellular homeostasis and disease[1][2][3][4][5].
Dephosphorylation of phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate at the 5-position, impacting downstream PI3K/AKT and STAT3 pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inositol polyphosphate-5-phosphatase F (INPP5F).